A dual treatment blocks alcohol binge-drinking relapse: Microbiota as a new player
dc.contributor.author | Ezquer, Fernando | |
dc.contributor.author | Quintanilla, María | |
dc.contributor.author | Morales, Paola | |
dc.contributor.author | Santapau, Daniela | |
dc.contributor.author | Munita, José | |
dc.contributor.author | Moya, Francisco | |
dc.contributor.author | Ezquer, Marcelo | |
dc.contributor.author | Herrera, Mario | |
dc.contributor.author | Israel, Yedy | |
dc.date.accessioned | 2022-11-14T19:43:16Z | |
dc.date.available | 2022-11-14T19:43:16Z | |
dc.date.issued | 2022 | |
dc.description.abstract | Rationale: Gut microbiota communicates information to the brain. Some animals are born with a gut microbiota that predisposes to high alcohol consumption, and transplantation of fecal material from alcoholics to mice increases animal preference for ethanol. Alcohol-use-disorders are chronic conditions where relapse is the hallmark. A predictive animal model of relapse is the "alcohol deprivation effect" where ethanol re-access is allowed following chronic alcohol intake and a long alcohol deprivation. The present study evaluates the effect of gut microbiota modification on relapse, as an adjunct to N-acetylcysteine + Acetylsalicylic acid administration, which inhibits the alcohol-induced hyper-glutamatergic condition. Methods: Rats bred as heavy alcohol consumers (UChB) were allowed ethanol intake for one month, were deprived of alcohol for two-weeks and subsequently offered re-access to ethanol. Prior to ethanol re-access animals received orally either (i) vehicle-control, (ii) Lactobacillus-rhamnosus-GG after antibiotic treatment (LGG); (iii) N-acetylcysteine+Acetylsalicylic acid (NAC/ASA) or (iv) both treatments: LGG+ (NAC/ASA). Results: Marked binge drinking (1.75 g ethanol/kg in 60 min) and blood alcohol levels exceeding 80 mg/dl were observed in the control group upon ethanol-re-access. Lactobacillus-GG or (NAC+ASA) treatments inhibited alcohol intake by 66-80%. The combination of both treatments virtually suppressed (inhibition of 90%) the re-access binge-like drinking, showing additive effects. Treatment with NAC+ASA increased the levels of glutamate transporters xCT and GLT-1 in nucleus accumbens, while Lactobacillus-GG administration increased those of the dopamine transporter (DAT). Conclusions: The administration of a well-accepted probiotic may be of value as an adjunct in the treatment of alcohol-use-disorders. | es |
dc.description.version | Versión publicada | es |
dc.identifier.citation | Ezquer F, Quintanilla ME, Morales P, Santapau D, Munita JM, Moya-Flores F, Ezquer M, Herrera-Marschitz M, Israel Y. A dual treatment blocks alcohol binge-drinking relapse: Microbiota as a new player. Drug Alcohol Depend. 2022 Jul 1;236:109466. doi: 10.1016/j.drugalcdep.2022.109466 | es |
dc.identifier.uri | https://doi.org/10.1016/j.drugalcdep.2022.109466 | es |
dc.identifier.uri | http://hdl.handle.net/11447/6659 | |
dc.language.iso | en | es |
dc.subject | ADE | es |
dc.subject | Alcohol relapse | es |
dc.subject | Gut microbiota | es |
dc.subject | Lactobacillus | es |
dc.subject | Treatment | es |
dc.title | A dual treatment blocks alcohol binge-drinking relapse: Microbiota as a new player | es |
dc.type | Article | es |
dcterms.source | Drug and Alcohol Dependence | es |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- A dual treatment blocks alcohol binge-drinking relapse Microbiota as a.pdf
- Size:
- 3.39 MB
- Format:
- Adobe Portable Document Format
- Description:
- Texto completo
License bundle
1 - 1 of 1
No Thumbnail Available
- Name:
- license.txt
- Size:
- 1.71 KB
- Format:
- Item-specific license agreed upon to submission
- Description: